Skip to content

Boosted saquinavir has similar potency, better lipid profile than lopinavir/r in naïve patients: interim results from GEMINI study

ARVs for Russian injecting drug users 'in best interests of public health and economics'

2001 Doha trade agreement failing to improve access to medicines, Oxfam says

Insulin resistance increases risk of brain impairment for adults with HIV

Heavy drinking linked to risky sex in Botswana

World Health Organization and experts call for $95 million in emergency funding to combat XDR-TB

US researchers estimate HIV treatment will work for 24 years and cost £200k

Genetically modified HIV shows early promise as a gene therapy viral vector

Fear of increased appetite proves obstacle to adherence in Rwanda